Delivery Order SPE2DB22D1202-SPE2DB25FUTC4

Award Date 2/19/25
Potential Completion Date 3/12/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,604.63, is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,604.63, is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. It is a firm fixed-price delivery order contract with a completion date of March 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product, with a ceiling value of $12,604.63 and a period of performance through February 13, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific business designation. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,827.51 firm-fixed-price contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of December 9, 2024 and was awarded on November 15, 2024. It is part of a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,236.27 firm fixed-price contract is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of January 10, 2025. Amerisourcebergen Drug Corp is the prime...
This federal contract award, valued at $12,236.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $61,181.35, is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty pharmaceutical product. The delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, with a ceiling value of $12,236.27 and a performance period through December 24, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,236.27, is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. The $23,655.02 firm-fixed-price contract has a completion date of November 14, 2024. The award is not associated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUTC4
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,604.63, is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. The contract is a firm fixed-price type and has an ultimate completion date of March 12, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 9:43 AM